Beam Therapeutics, Inc.(BEAM)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

BEAM Beam Therapeutics, Inc.

已收盘 11-26 16:00:00 EST

25.84

-0.81

-3.04%

盘后25.84

+0.000.00%

17:41 EST

最高27.19	最低25.09	成交量71.63万
今开26.47	昨收26.65	日振幅7.88%
总市值21.40亿	流通市值17.64亿	总股本8,281万
成交额1,845万	换手率1.05%	流通股本6,827万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"BEAM","market":"US","secType":"STK","nameCN":"Beam Therapeutics, Inc.","latestPrice":25.84,"timestamp":1732654800000,"preClose":26.65,"halted":0,"volume":716259,"hourTrading":{"tag":"盘后","latestPrice":25.84,"preClose":25.84,"latestTime":"17:41 EST","volume":30362,"amount":784597.38,"timestamp":1732660879595},"delay":0,"floatShares":68269300,"shares":82805627,"eps":-1.754729,"marketStatus":"已收盘","marketStatusCode":5,"change":-0.81,"latestTime":"11-26 16:00:00 EST","open":26.47,"high":27.19,"low":25.09,"amount":18445053.062388,"amplitude":0.078799,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.754729,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1732698000000},"adr":0,"listingDate":1580965200000,"adjPreClose":26.65,"preHourTrading":{"tag":"盘前","latestPrice":26.5,"preClose":26.65,"latestTime":"09:29 EST","volume":192,"amount":5086.32,"timestamp":1732631399907},"postHourTrading":{"tag":"盘后","latestPrice":25.84,"preClose":25.84,"latestTime":"17:41 EST","volume":30362,"amount":784597.38,"timestamp":1732660879595},"volumeRatio":0.619481,"impliedVol":0.6112,"impliedVolPercentile":0.3439},"requestUrl":"/m/hq/s/BEAM/wiki","defaultTab":"wiki","newsList":[{"id":"2486811000","title":"Beam Therapeutics Inc.盘中异动 股价大跌5.07%报25.30美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2486811000","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486811000?lang=zh_cn&edition=full","pubTime":"2024-11-26 23:22","pubTimestamp":1732634572,"startTime":"0","endTime":"0","summary":"北京时间2024年11月26日23时22分，Beam Therapeutics Inc.股票出现异动，股价大幅下跌5.07%。截至发稿，该股报25.30美元/股，成交量10.7769万股，换手率0.13%，振幅6.57%。Beam Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为0.37%。Beam Therapeutics Inc.公司简介：Beam Therapeutics Inc 是一家从事基于其碱基编辑技术创造基因药物的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241126232252971a8aa4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241126232252971a8aa4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","BEAM","BK4139","BK4535","BK4556","LENZ","BK4505","BK4588"],"gpt_icon":0},{"id":"2485296420","title":"Beam Therapeutics Inc.盘中异动 临近午盘股价大涨5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2485296420","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485296420?lang=zh_cn&edition=full","pubTime":"2024-11-23 00:42","pubTimestamp":1732293774,"startTime":"0","endTime":"0","summary":"北京时间2024年11月23日00时42分，Beam Therapeutics Inc.股票出现波动，股价快速上涨5.00%。Beam Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.75%。其相关个股中，Apollomics Inc C/Wts 01/04/2028 、Exicure, Inc.、Replimune Group, Inc.涨幅较大，Virpax Pharmaceuticals, Inc.、Exicure, Inc.、Molecular Templates, Inc.较为活跃，换手率分别为1798.57%、131.35%、91.29%，振幅较大的相关个股有Virpax Pharmaceuticals, Inc.、Apollomics Inc C/Wts 01/04/2028 、Exicure, Inc.，振幅分别为66.95%、63.64%、45.86%。Beam Therapeutics Inc.公司简介：Beam Therapeutics Inc 是一家从事基于其碱基编辑技术创造基因药物的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241123004254abd7c810&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241123004254abd7c810&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BEAM","BK4139","BK4585","BK4505","LENZ","BK4535","BK4556","BK4588"],"gpt_icon":0},{"id":"2484190309","title":"Beam Therapeutics Inc.盘中异动 股价大涨5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2484190309","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484190309?lang=zh_cn&edition=full","pubTime":"2024-11-20 04:57","pubTimestamp":1732049838,"startTime":"0","endTime":"0","summary":"北京时间2024年11月20日04时57分，Beam Therapeutics Inc.股票出现异动，股价急速拉升5.06%。Beam Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为1.68%。其相关个股中，Silexion Therapeutics Corp C/Wts Exp 15/08/2029 、Abpro Holdings Inc C/Wts 12/11/2029 、Exicure, Inc.涨幅较大，Syros Pharmaceuticals, Inc.、Tff Pharmaceuticals, Inc.、Exicure, Inc.较为活跃，换手率分别为1350.25%、857.26%、167.97%，振幅较大的相关个股有Syros Pharmaceuticals, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 ，振幅分别为91.10%、81.67%、78.21%。Beam Therapeutics Inc.公司简介：Beam Therapeutics Inc 是一家从事基于其碱基编辑技术创造基因药物的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112004571898e4395f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112004571898e4395f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4585","BK4556","BK4139","BEAM","BK4535","BK4588","BK4505"],"gpt_icon":0},{"id":"2483729533","title":"Beam Therapeutics Inc.盘中异动 早盘大幅跳水5.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483729533","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483729533?lang=zh_cn&edition=full","pubTime":"2024-11-15 22:39","pubTimestamp":1731681596,"startTime":"0","endTime":"0","summary":"北京时间2024年11月15日22时39分，Beam Therapeutics Inc.股票出现异动，股价快速下挫5.23%。Beam Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为1.77%。其相关个股中，Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Silexion Therapeutics Corp C/Wts Exp 15/08/2029 、Cero Therapeutics Holdings, Inc.涨幅较大，Tc Biopharm  Plc、Elevai Labs, Inc.、Cero Therapeutics Holdings, Inc.较为活跃，换手率分别为2867.59%、209.22%、171.60%，振幅较大的相关个股有Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Silexion Therapeutics Corp C/Wts Exp 15/08/2029 、Cero Therapeutics Holdings, Inc.，振幅分别为125.68%、114.92%、62.87%。Beam Therapeutics Inc.公司简介：Beam Therapeutics Inc 是一家从事基于其碱基编辑技术创造基因药物的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111522395698e42f15&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111522395698e42f15&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4535","BK4588","BK4505","LENZ","BK4139","BK4556","BK4585","BEAM"],"gpt_icon":0},{"id":"2483356780","title":"Beam Therapeutics Inc.盘中异动 临近午盘股价大跌5.01%报28.83美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483356780","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483356780?lang=zh_cn&edition=full","pubTime":"2024-11-13 00:44","pubTimestamp":1731429897,"startTime":"0","endTime":"0","summary":"北京时间2024年11月13日00时44分，Beam Therapeutics Inc.股票出现异动，股价急速跳水5.01%。截至发稿，该股报28.83美元/股，成交量63.6361万股，换手率0.77%，振幅5.85%。Beam Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为0.56%。Beam Therapeutics Inc.公司简介：Beam Therapeutics Inc 是一家从事基于其碱基编辑技术创造基因药物的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111300445798e42231&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111300445798e42231&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4556","BK4139","LENZ","BK4535","BK4585","BEAM","BK4588","BK4505"],"gpt_icon":0},{"id":"1125060898","title":"异动解读 | Beam Therapeutics股价大涨 基因编辑技术前景获看好","url":"https://stock-news.laohu8.com/highlight/detail?id=1125060898","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1125060898?lang=zh_cn&edition=full","pubTime":"2024-11-12 10:40","pubTimestamp":1731379249,"startTime":"0","endTime":"0","summary":"生物科技公司Beam Therapeutics 股价在今晚夜盘大涨5.40%,报收28.43美元。据分析,该股涨势或与公司基因编辑技术的发展前景获市场看好有关。作为基因编辑领域的创新者,Beam Therapeutics利用自主研发的碱基编辑技术,可精准编辑基因组中的单个碱基,无需引起DNA双链断裂。公司目前管线中有多个针对遗传性疾病的在研项目,如治疗镰状细胞病和β地中海贫血症的BEAM-101、针对α1抗酵素缺陷性肝病的BEAM-302等。随着这些项目的临床数据陆续公布,Beam Therapeutics的股价反应良好,前景值得期待。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["BEAM"],"gpt_icon":0},{"id":"1111253393","title":"异动解读 | Beam Therapeutics股价大涨6.32% 基因编辑技术前景获看好","url":"https://stock-news.laohu8.com/highlight/detail?id=1111253393","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1111253393?lang=zh_cn&edition=full","pubTime":"2024-11-11 22:45","pubTimestamp":1731336342,"startTime":"0","endTime":"0","summary":"生物科技公司Beam Therapeutics股价今日盘中大涨6.32%,报28.43美元。市场分析人士认为,此轮涨势或与公司基因编辑技术的发展前景获市场看好有关。作为一家基因编辑领域的创新公司,Beam Therapeutics利用自主研发的碱基编辑技术,可在不引起DNA双链断裂的情况下,精准编辑基因组中的单个碱基。公司目前管线中包括多个针对各类遗传性疾病的在研项目,如BEAM-101用于治疗sicklecell病和β地中海贫血症、BEAM-302用于治疗α1抗酵素缺陷性肝病等。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"异动解读 | Beam Therapeutics股价大涨6.32% 基因编辑技术前景获看好","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["BEAM"],"gpt_icon":0},{"id":"2482738827","title":"Beam Therapeutics Inc.盘中异动 快速拉升5.06%报28.43美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2482738827","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482738827?lang=zh_cn&edition=full","pubTime":"2024-11-11 22:36","pubTimestamp":1731335789,"startTime":"0","endTime":"0","summary":"北京时间2024年11月11日22时36分，Beam Therapeutics Inc.股票出现异动，股价快速拉升5.06%。截至发稿，该股报28.43美元/股，成交量5.8637万股，换手率0.07%，振幅3.68%。Beam Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为0.33%。Beam Therapeutics Inc.公司简介：Beam Therapeutics Inc 是一家从事基于其碱基编辑技术创造基因药物的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241111223629a22ce70f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241111223629a22ce70f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4535","LENZ","BEAM","BK4588","BK4505","BK4585","BK4139","BK4556"],"gpt_icon":0},{"id":"2482226201","title":"Beam Therapeutics Inc.2024财年第三财季实现净利润-96.67百万美元，同比减少0.60%","url":"https://stock-news.laohu8.com/highlight/detail?id=2482226201","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482226201?lang=zh_cn&edition=full","pubTime":"2024-11-11 00:00","pubTimestamp":1731254443,"startTime":"0","endTime":"0","summary":"11月11日，Beam Therapeutics Inc.公布财报，公告显示公司2024财年第三财季净利润为-96.67百万美元，同比减少0.60%；其中营业收入为14.27百万美元，同比减少16.99%，每股基本收益为-1.17美元。从资产负债表来看，Beam Therapeutics Inc.总负债3.80亿美元，其中短期债务12.94百万美元，资产负债比为3.09，流动比率为5.70。机构评级：截至2024年11月11日，当前有15家机构对Beam Therapeutics Inc.目标价做出预测，其中目标均价为49.20美元，其中最低目标价为23.00美元，最高目标价为80.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241111000108a229e3a9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241111000108a229e3a9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BEAM"],"gpt_icon":0},{"id":"1108923217","title":"异动解读 | Beam Therapeutics股价大涨逾14% 基因编辑行业前景看好","url":"https://stock-news.laohu8.com/highlight/detail?id=1108923217","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1108923217?lang=zh_cn&edition=full","pubTime":"2024-11-07 10:42","pubTimestamp":1730947358,"startTime":"0","endTime":"0","summary":"Beam Therapeutics Inc.今日盘中股价大涨14%,引发市场关注。公司所处的基因编辑行业被看好,成为股价上涨的主要推手。公开信息显示,知名机构投资者ARK Invest基金经理Cathie Wood看好Beam Therapeutics等基因编辑公司的长期发展前景。作为该领域的先驱企业,Beam Therapeutics有望凭借自身技术优势受益于行业发展红利。此外,市场对Beam Therapeutics业绩增长保持乐观预期。公司最新财报显示,营收同比增长,毛利率也有所提高。不过,分析师也对公司后续发展存在不同观点,有所调降目标价格。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["BEAM"],"gpt_icon":0},{"id":"2481990482","title":"athie Wood布局新一轮科技热潮——白宫谁胜出都无关紧要","url":"https://stock-news.laohu8.com/highlight/detail?id=2481990482","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481990482?lang=zh_cn&edition=full","pubTime":"2024-11-07 08:11","pubTimestamp":1730938264,"startTime":"0","endTime":"0","summary":"ARK Invest的Cathie Wood正在为一个支持变革性技术的白宫政府布局。这位公司首席执行官兼首席投资官认为，无论谁赢得总统大选，较少的监管将引发一场科技热潮。去年上涨了近68%的ARK Innovation ETF在2024年下跌了约8%。自拜登总统上任以来，该基金也大幅下滑。ARKK持有的科技公司尤其对利率上升敏感。Wood认为，这种不佳表现只是暂时的。“CRISPR Therapeutics和Beam Therapeutics等公司已经开发出了治愈疾病的方法，”Wood表示。CRISPR在过去一个月上涨了11%，而Beam上涨了2%。ARK Genomic Revolution ETF持有这两只股票。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://usstock.jrj.com.cn/2024/11/07081145019009.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_highlight","symbols":["LU1914381329.SGD","BK4574","IE00B1XK9C88.USD","LU1551013425.SGD","LU0316494557.USD","BK4511","LU1720051108.HKD","LU1429558221.USD","BK4581","BK4533","LU1861220033.SGD","ARKK","LU2249611893.SGD","BK4555","BK4505","LU2357305700.SGD","LU2213496289.HKD","LU2023250330.USD","LU1861215975.USD","BK4139","LU0943347566.SGD","BK4527","SG9999015945.SGD","LU2326559502.SGD","BK4534","LU2063271972.USD","CRSP","BK4535","LU1839511570.USD","ARKG","LU0082616367.USD","LU0466842654.USD","FDN","TSLA","BEAM","LU0234572021.USD","IE00BSNM7G36.USD","LU0964807845.USD","LU1852331112.SGD","BK4548","LU0719512351.SGD","BK4099","LU1435385759.SGD","LU1720051017.SGD","IE00BJLML261.HKD","LU0198837287.USD","LU0820562030.AUD","LU0820561909.HKD","LU1629891620.HKD","LU0234570918.USD"],"gpt_icon":1},{"id":"2481988029","title":"Beam Therapeutics Inc.盘中异动 急速上涨9.61%报26.23美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2481988029","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481988029?lang=zh_cn&edition=full","pubTime":"2024-11-06 22:33","pubTimestamp":1730903581,"startTime":"0","endTime":"0","summary":"北京时间2024年11月06日22时33分，Beam Therapeutics Inc.股票出现异动，股价大幅上涨9.61%。截至发稿，该股报26.23美元/股，成交量12.276万股，换手率0.15%，振幅2.33%。Beam Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为0.12%。Beam Therapeutics Inc.公司简介：Beam Therapeutics Inc 是一家从事基于其碱基编辑技术创造基因药物的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110622330195bddb88&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110622330195bddb88&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","BK4535","BK4588","BK4505","BK4139","BK4556","LENZ","BEAM"],"gpt_icon":0},{"id":"2481624519","title":"美国研究综述-阿波罗、Booking Holdings、Portillos","url":"https://stock-news.laohu8.com/highlight/detail?id=2481624519","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481624519?lang=zh_cn&edition=full","pubTime":"2024-11-06 17:15","pubTimestamp":1730884501,"startTime":"0","endTime":"0","summary":"    路透11月6日 - 华尔街证券分析师周三调整了对几家美国上市公司的评级和目标价，其中包括阿波罗、Booking Holdings 和 Portillos。要闻 * 阿波罗  ：摩根大通将目标价从143美元上调至161美元 * Aris Water Solutions Inc   ：摩根大通将其评级从 \"增持 \"下调至 \"中性  * Booking Holdings Inc   ：Truist Securities将目标价从4100美元上调至4700美元  * Choice Hotels International Inc   ：杰富瑞将其评级从 \"买入 \"下调至 \"持有  * Portillos Inc   ：Stifel将其评级从 \"买入 \"下调至 \"持有  以下是路透周三报道的美国公司研究报告摘要。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CMI","BK4113","BOW","GO","AIG","CE","EMN","BEAM","CTRE","ACLX","APO","LU0029874061.USD","EXAS","DBRG","CC","ALL","BKNG","BK4141","HPK","APLS","BVS","AVB","FIS","CHH","BRKR","GXO","LU0390134368.USD","LU2065171311.SGD","MO","AGCO","BR","LU0426417589.USD","ADUS","INZY","FRPT","ARIS","LU0708994859.HKD","BLDR","ABNB","LU0868494708.USD","GMED","AHCO","ABBV","ANAB","IT","EMR","AMH","LU2065169927.USD","AZPN","GFS"],"gpt_icon":0},{"id":"1174325590","title":"异动解读 | 生物技术公司Beam Therapeutics临床试验发生患者死亡,股价大跌17.69%","url":"https://stock-news.laohu8.com/highlight/detail?id=1174325590","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1174325590?lang=zh_cn&edition=full","pubTime":"2024-11-05 23:42","pubTimestamp":1730821353,"startTime":"0","endTime":"0","summary":"生物技术公司Beam Therapeutics(BEAM)11月5日股价大跌17.69%,主要原因是其基于CRISPR技术的细胞疗法BEAM-101早期临床试验中发生一名镰状细胞病患者死亡事故。\n\n据报道,该名患者死于呼吸衰竭,很可能与为患者BEAM-101细胞输注做准备时使用的\"busulfan\"化疗调理药物有关。患者在输注BEAM-101治疗约四个月后不幸去世。\n\n尽管这一事件极为不幸,但也凸显了当前临床试验方案和预处理方案仍需进一步改进以减少不良反应风险。公司目前已有8名患者接受了BEAM-101治疗。Beam Therapeutics第三季度净亏损9670万美元,同比去年略有增加。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["BEAM"],"gpt_icon":0},{"id":"2481899596","title":"BUZZ-早期试验中患者死亡，Beam Therapeutics 公司业绩下滑","url":"https://stock-news.laohu8.com/highlight/detail?id=2481899596","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481899596?lang=zh_cn&edition=full","pubTime":"2024-11-05 23:40","pubTimestamp":1730821201,"startTime":"0","endTime":"0","summary":"    11月5日 - ** 生物技术公司Beam Therapeutics   股价下跌3.30%，至23.56美元** 摘要显示，在该公司基于CRISPR技术的细胞疗法BEAM-101的早中期试验中，一名镰状细胞病患者因呼吸衰竭死亡。** Vertex  和CRISPR Therapeutics的  Casgevy和蓝鸟生物的  Lyfgenia被批准用于治疗镰状细胞病，这是一组遗传性血液疾病。** BEAM 第三季度净亏损为 9,670 万美元，合每股亏损 1.17 美元，去年同期净亏损为 9,610 万美元，合每股亏损 1.22 美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B19Z9P08.USD","LU0109394709.USD","IE00BJJMRZ35.SGD","LU2237438978.USD","LU2462157665.USD","LU0079474960.USD","LU1585245621.USD","LU2236285917.USD","BK4578","IE00B894F039.SGD","LENZ","IE00B19Z3B42.SGD","LU0061475181.USD","IE00BZ9MQY76.HKD","LU0823416689.USD","IE00B19Z9Z06.USD","LU1069344957.HKD","IE00B4R5TH58.HKD","LU0889565916.HKD","IE0002270589.USD","BK4139","BEAM","LU1093756168.USD","BK4588","LU1430594728.SGD","LU2417539215.USD","BK4556","BK4567","BK4585","LU1093756325.SGD","LU2362540622.SGD","IE00BFTCPJ56.SGD","BK4505","LU0234570918.USD","LU2324357040.USD","BLUE","BK4532","LU0058720904.USD","IE00B19Z3581.USD","IE0009355771.USD","VRTX","LU2456880835.USD","BK4535","IE00BJT1NW94.SGD","LU0256863811.USD","LU0289739699.SGD","LU0417517546.SGD","LU2362541513.USD","BK4533","IE0002141913.USD"],"gpt_icon":0},{"id":"2481532459","title":"Beam Therapeutics Inc.盘中异动 股价大涨5.02%报24.08美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2481532459","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481532459?lang=zh_cn&edition=full","pubTime":"2024-11-05 01:41","pubTimestamp":1730742068,"startTime":"0","endTime":"0","summary":"北京时间2024年11月05日01时41分，Beam Therapeutics Inc.股票出现异动，股价急速拉升5.02%。截至发稿，该股报24.08美元/股，成交量40.6889万股，换手率0.49%，振幅6.78%。Beam Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为0.01%。Beam Therapeutics Inc.公司简介：Beam Therapeutics Inc 是一家从事基于其碱基编辑技术创造基因药物的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241105014109971a439c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241105014109971a439c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4535","BK4139","BK4556","BK4505","LENZ","BK4585","BEAM","BK4588"],"gpt_icon":0},{"id":"2480583277","title":"Beam Therapeutics Inc.盘中异动 下午盘急速拉升5.13%报23.04美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2480583277","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480583277?lang=zh_cn&edition=full","pubTime":"2024-11-02 01:03","pubTimestamp":1730480586,"startTime":"0","endTime":"0","summary":"北京时间2024年11月02日01时03分，Beam Therapeutics Inc.股票出现异动，股价快速上涨5.13%。截至发稿，该股报23.04美元/股，成交量29.5149万股，换手率0.36%，振幅4.31%。Beam Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.59%。Beam Therapeutics Inc.公司简介：Beam Therapeutics Inc 是一家从事基于其碱基编辑技术创造基因药物的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241102010306ab93ce16&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241102010306ab93ce16&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4556","BEAM","LENZ","BK4139","BK4585","BK4505","BK4588","BK4535"],"gpt_icon":0},{"id":"2478489861","title":"Beam Therapeutics Inc.盘中异动 急速拉升5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2478489861","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478489861?lang=zh_cn&edition=full","pubTime":"2024-10-28 21:52","pubTimestamp":1730123574,"startTime":"0","endTime":"0","summary":"北京时间2024年10月28日21时52分，Beam Therapeutics Inc.股票出现波动，股价急速拉升5.01%。Beam Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.59%。其相关个股中，Nls Pharmaceutics Ltd C/Wts 02/02/2026、Klotho Neurosciences Inc C/Wts 21/06/2029 、Monte Rosa Therapeutics, Inc.涨幅较大，Tc Biopharm  Plc、Viracta Therapeutics, Inc.、Immunoprecise Antibodies Ltd.较为活跃，换手率分别为576.57%、50.99%、39.20%，振幅较大的相关个股有Nls Pharmaceutics Ltd C/Wts 02/02/2026、Tevogen Bio Holdings Inc C/Wts 14/02/2029 、Monte Rosa Therapeutics, Inc.，振幅分别为87.13%、45.41%、29.24%。Beam Therapeutics Inc.公司简介：Beam Therapeutics Inc 是一家从事基于其碱基编辑技术创造基因药物的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241028215254971a2a80&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241028215254971a2a80&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","BK4535","BK4588","BK4505","BK4139","BK4556","LENZ","BEAM"],"gpt_icon":0},{"id":"2476174647","title":"Beam Therapeutics Inc.盘中异动 早盘快速下跌5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2476174647","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2476174647?lang=zh_cn&edition=full","pubTime":"2024-10-17 22:29","pubTimestamp":1729175360,"startTime":"0","endTime":"0","summary":"北京时间2024年10月17日22时29分，Beam Therapeutics Inc.股票出现波动，股价急速下跌5.02%。Beam Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.27%。其相关个股中，Psyence Biomedical Ltd C/Wts 25/01/2029、Klotho Neurosciences Inc C/Wts 21/06/2029 、Tevogen Bio Holdings Inc.涨幅较大，Notable Labs, Ltd.、Molecular Templates, Inc.、Zyversa Therapeutics, Inc.较为活跃，换手率分别为336.56%、282.72%、160.60%，振幅较大的相关个股有Klotho Neurosciences Inc C/Wts 21/06/2029 、Psyence Biomedical Ltd C/Wts 25/01/2029、Molecular Templates, Inc.，振幅分别为104.84%、56.36%、50.57%。Beam Therapeutics Inc.公司简介：Beam Therapeutics Inc 是一家从事基于其碱基编辑技术创造基因药物的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241017222920a1e16ac6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241017222920a1e16ac6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4505","BK4556","BK4588","LENZ","BK4535","BEAM","BK4585"],"gpt_icon":0},{"id":"2475399660","title":"Beam Therapeutics Inc.盘中异动 早盘股价大涨5.02%报25.96美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2475399660","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2475399660?lang=zh_cn&edition=full","pubTime":"2024-10-14 23:16","pubTimestamp":1728919002,"startTime":"0","endTime":"0","summary":"北京时间2024年10月14日23时16分，Beam Therapeutics Inc.股票出现异动，股价大幅上涨5.02%。截至发稿，该股报25.96美元/股，成交量29.5163万股，换手率0.36%，振幅5.56%。Beam Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为0.57%。Beam Therapeutics Inc.公司简介：Beam Therapeutics Inc 是一家从事基于其碱基编辑技术创造基因药物的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241014231642971a023c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241014231642971a023c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BEAM","BK4588","LENZ","BK4556","BK4585","BK4535","BK4505"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.beamtx.com","stockEarnings":[{"period":"1week","weight":0.1049},{"period":"1month","weight":0.2367},{"period":"3month","weight":0.0137},{"period":"6month","weight":0.1254},{"period":"1year","weight":-0.1018},{"period":"ytd","weight":-0.0209}],"compareEarnings":[{"period":"1week","weight":0.0159},{"period":"1month","weight":0.0319},{"period":"3month","weight":0.0641},{"period":"6month","weight":0.1358},{"period":"1year","weight":0.3124},{"period":"ytd","weight":0.2571}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Beam Therapeutics Inc.成立于2017年1月25日，是一家生物技术公司，致力于根据其专有的碱基编辑技术创建一类新型的精密基因药物，其愿景是为患有严重疾病的患者提供终身治疗疾病。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.014255},{"month":2,"riseRate":0.5,"avgChangeRate":0.150231},{"month":3,"riseRate":0,"avgChangeRate":-0.194539},{"month":4,"riseRate":0.4,"avgChangeRate":-0.157847},{"month":5,"riseRate":0.6,"avgChangeRate":0.130913},{"month":6,"riseRate":0.8,"avgChangeRate":0.165215},{"month":7,"riseRate":0.4,"avgChangeRate":0.069935},{"month":8,"riseRate":0.4,"avgChangeRate":-0.006987},{"month":9,"riseRate":0.2,"avgChangeRate":-0.081345},{"month":10,"riseRate":0.4,"avgChangeRate":0.021253},{"month":11,"riseRate":0.8,"avgChangeRate":0.189575},{"month":12,"riseRate":0.5,"avgChangeRate":0.113929}],"exchange":"NASDAQ","name":"Beam Therapeutics, Inc.","nameEN":"Beam Therapeutics, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Beam Therapeutics, Inc.(BEAM)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Beam Therapeutics, Inc.(BEAM)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Beam Therapeutics, Inc.,BEAM,Beam Therapeutics, Inc.股票,Beam Therapeutics, Inc.股票老虎,Beam Therapeutics, Inc.股票老虎国际,Beam Therapeutics, Inc.行情,Beam Therapeutics, Inc.股票行情,Beam Therapeutics, Inc.股价,Beam Therapeutics, Inc.股市,Beam Therapeutics, Inc.股票价格,Beam Therapeutics, Inc.股票交易,Beam Therapeutics, Inc.股票购买,Beam Therapeutics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Beam Therapeutics, Inc.(BEAM)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Beam Therapeutics, Inc.(BEAM)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}